Our data revealed that decreased ASS1 caused by attenuation of VIP/VIPR1 signaling in HCC promotes phosphorylation of CAD through the mTOR/p70S6K pathway, which then promotes HCC growth/recurrence and proliferation. The gene discussed is MTOR; the disease is hepatocellular carcinoma.